...
首页> 外文期刊>British Journal of Cancer >In vivo-in vitro clonogenic assays in a human tumour xenograft with a high plating efficiency
【24h】

In vivo-in vitro clonogenic assays in a human tumour xenograft with a high plating efficiency

机译:具有高接种效率的人肿瘤异种移植物中的体内-体外克隆形成测定

获取原文

摘要

The HT29R human colonic adenocarcinoma cell line grows as locally invasive, mucin-secreting tumours in immunosuppressed mice with a doubling time of 6 days. These tumours may be disaggregated to give single-cell suspensions with plating efficiencies of 25-45% in technically simple in vivo-in vitro cell-survival assays. The effect of maximum tolerated doses of 5-fluorouracil, melphalan and cyclo-phosphamide on in situ growth is only slight. in vivo-in vitro cell-survival assays phosphamide on in situ growth is only slight. in vivo-in vitro cell-survival assays are consistent with these in situ results. The relative ease of experimental manipulation and the high clonogenic efficiency of this tumour make it a useful addition to human tumour xenograft models.
机译:HT29R人结肠腺癌细胞系在免疫抑制的小鼠中以局部侵袭性,粘液分泌性肿瘤的形式生长,其倍增时间为6天。在技​​术上简单的体内-体外细胞存活试验中,可以将这些肿瘤分解为单细胞悬液,接种效率为25-45%。 5-氟尿嘧啶,美法仑和环磷酰胺的最大耐受剂量对原位生长的影响很小。体内-体外细胞存活试验磷酰胺对原位生长的影响很小。体内-体外细胞存活测定与这些原位结果一致。实验操作的相对容易性和该肿瘤的高克隆形成效率使其成为人肿瘤异种移植模型的有用补充。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号